Golden Life Medicine Group (01110) issues profit warning, expecting a net loss of approximately 4.5 million yuan attributable to owners in the first half of the year, a turnaround from profit to loss compared to the same period last year.

The China Fortune Financial News App announced that Jinhuo Pharmaceutical Group (01110) expects a decrease in net profit of about 70% to 75% in the first half of 2025 compared to the first half of 2024, when the net profit was 45.6 million yuan. The expected loss attributable to the company's owners is about 4.5 million yuan, while the net profit attributable to the company's owners in the first half of 2024 was about 30.7 million yuan.